DA
XBI icon

Doliver Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Doliver Advisors’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$488K Hold
3,082
– – 0.11% 128
2026
Q1 		$394K Sell
3,082
-25
-0.8% -$3.12K 0.09% 134
2025
Q4 		$379K Sell
3,107
-50
-2% -$5.73K 0.09% 133
2025
Q3 		$316K Sell
3,157
-75
-2% -$6.75K 0.08% 153
2025
Q2 		$268K Hold
3,232
– – 0.07% 150
2025
Q1 		$262K Sell
3,232
-80
-2% -$7.15K 0.07% 144
2024
Q4 		$298K Sell
3,312
-50
-1% -$4.84K 0.08% 132
2024
Q3 		$332K Sell
3,362
-100
-3% -$9.82K 0.09% 119
2024
Q2 		$321K Buy
3,462
+1,100
+47% +$98.6K 0.09% 117
2024
Q1 		$224K Sell
2,362
-50
-2% -$4.64K 0.06% 136
2023
Q4 		$215K Buy
+2,412
New +$179K 0.07% 138
2023
Q3 		– Sell
-2,537
Closed -$211K – 164
2023
Q2 		$211K Sell
2,537
-175
-6% -$14.6K 0.06% 157
2023
Q1 		$207K Sell
2,712
-413
-13% -$34.3K 0.06% 154
2022
Q4 		$259K Sell
3,125
-15
-0.5% -$1.21K 0.09% 126
2022
Q3 		$249K Sell
3,140
-587
-16% -$49.5K 0.09% 124
2022
Q2 		$277K Buy
3,727
+437
+13% +$32.8K 0.1% 130
2022
Q1 		$296K Buy
+3,290
New +$304K 0.09% 135

Other funds holding XBI

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
AAS
Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return
WAM
Weatherly Asset Management Del Mar, California $1.4B AUM 36.32% 1-Year Est. Return
RFM
Royal Fund Management Lady Lake, Florida $1.2B AUM 32.21% 1-Year Est. Return
NHFG
New Harbor Financial Group Worcester, Massachusetts $633M AUM 37.53% 1-Year Est. Return
MFS
Madrona Financial Services Everett, Washington $543M AUM 30.87% 1-Year Est. Return
LRPA
L. Roy Papp & Associates Phoenix, Arizona $951M AUM 29.05% 1-Year Est. Return
SGH
Sivik Global Healthcare Greenwich, Connecticut $132M AUM 24.1% 1-Year Est. Return
EWM
Edge Wealth Management New York $594M AUM 24.92% 1-Year Est. Return

Doliver Advisors's XBI Position: Q2 2026 in Review

Doliver Advisors held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2026 at 3,082 shares worth $488K. The position accounts for 0.11% of the portfolio, ranked #128.

Doliver Advisors first reported a position in XBI in Q1 2022 and has held it in 17 quarters since. 225 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • Doliver Advisors held 3,082 shares of State Street SPDR S&P Biotech ETF worth $488K as of Q2 2026.
  • Doliver Advisors left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2026.
  • State Street SPDR S&P Biotech ETF made up 0.11% of Doliver Advisors's portfolio in Q2 2026, its #128 holding.
  • Doliver Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q1 2022 and has held it in 17 quarters since.
  • 225 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Doliver Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.